Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
ZERVIATE™ (cetirizine ophthalmic solution) 0.24%, for topical ophthalmic use These highlights do not include all the information needed to use ZERVIATE safely and effectively. See full prescribing information for ZERVIATE. Initial U.S. Approval: 1995
Medication labelWhy this: Advisory · dailymed-prescription
ZERVIATE™ (cetirizine ophthalmic solution) 0.24% is indicated for the treatment of ocular itching associated with allergic conjunctivitis.
- generic_name
- cetirizine
- product_names
- Cetirizine
- ndc
- 71776-024, 71776-024-05, 71776-024-01, 71776-024-30
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en